LigIT

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

LigIT - overview

Established

2026

Location

Beijing, Beijing, China

Primary Industry

Biotechnology

About

Based in Beijing, China and founded in 2026, Litai Zhiyao (Beijing) Technology Co. , Ltd. , dba LigIT, is an AI-native pharmaceutical company aiming to applying the methodologies to real-world drug discovery scenarios for further verification and implementation. The company's founder, Yinjun Jia, conducted postdoctoral research at Tsinghua University's Institute for AI Industry Research (AIR).


In October 2026, LigIT raised approximately CNY 50 million in Seed funding from Kexun Ruijin Capital, Lighthouse Capital, and other investors. LigIT focuses on developing its own proprietary drug pipelines, targeting oncology, autoimmune diseases, and metabolic disorders, leveraging an AI platform spanning synthetic data, peptide generation models. The company also engages in platform partnerships and joint R&D with pharmaceutical companies, biotech firms, hospitals, and national key laboratories. The company generates revenue from developing innovative peptide drugs leveraging AI technology and providing AI technology service in pharmaceutical R&D.


The company will primarily use the Seed funding for core pipeline R&D, investment in computing power, patent portfolio development, talent recruitment, and daily operations.


Primary Industry

Biotechnology

Sub Industries

Biopharmaceuticals, Molecular Science, Genetics & Gene Therapy, Pharmaceutical Research & Development, Scientific Software, Medical Software

Verticals

Artificial Intelligence, HealthTech

Company Stage

Angel & Seed

Total Amount Raised

Subscriber access only

GoingPro

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.